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Summary
Outer membrane vesicles (OMV) are released by
many bacteria, and contain immunogenic antigens
in addition to harmful inflammatory factors, like
lipopolysaccharides. Chemically detoxified OMV
have been used in vaccines against Neisseria
meningitidis (Nm); however, little is known about
their interaction with antigen presenting cells. In
this study, we investigated the interaction of Nm
OMV with human dendritic cells (DC) to gain
further understanding of their biological activity.
We engineered a novel serogroup B Nm that is
unencapsulated (siaD), expresses pentacylated
lipid A (lpxL1), hence conferring reduced toxicity,
and expresses an lgtB oligosaccharide structure
designed to target OMV to DC via DC-SIGN. We
show that the lgtB moiety is critical for internaliza-
tion of NOMV by DC. Furthermore, the lgtB moiety
significantly enhances DC maturation, IL-10 and
IL-23 production in the presence of a pentacylated
lipid A. While different DC phenotypes were
observed for each NOMV, this had little effect on
Th1 and Th2 cell differentiation; however, lgtB
significantly increased Th17 cell expansion in the
presence of pentacylated lipid A. We believe that
lpxL1/lgtB NOMV should be considered further
as a vaccine vector, particularly considering the
importance of lgtB in antigen uptake and further
human studies on antigen-specific responses
should be considered.
Introduction
Neisseria meningitidis (Nm) is a major cause of meningitis
and septicaemia worldwide. Effective capsular poly-
saccharide vaccines have been developed against
serogroups A, C, W135 and Y (Jodar et al., 2002;
Harrison, 2006). The development of a vaccine against
serogroup B has been difficult as the capsular
polysaccharide, which is structurally similar to human
neural glycans (Finne et al., 1983), is poorly immuno-
genic, therefore alternative antigens to the capsule have
been investigated. Reverse vaccinology techniques have
identified a number of outer membrane proteins such as
Factor H-binding protein (fHbp), Neisserial Adhesin A
(NadA) and Neisserial Heparin Binding Antigen (NHBA),
that can confer cross protection against a range of
serogroup B strains (Pizza et al., 2000; Giuliani et al.,
2006). A number of these outer membrane lipoproteins
have been included in the recently licensed vaccine
Bexsero® (Toneatto et al., 2011). This vaccine has been a
major achievement for the meningococcal field however,
vaccine coverage predictions show it is unlikely to protect
against all meningococcal B strains, and thus far there
has been no wide spread introduction of this vaccine.
Therefore it is vital work continues to understand how Nm
interacts with the immune system to further improve
current meningococcal vaccines.
Nm naturally sheds it outer membrane releasing vesi-
cles into the environment. These outer membrane vesi-
cles (OMV) are representative of the bacterial cell surface,
and so contain outer membrane proteins (OMP) but also
toxic lipooligosaccharide (LOS). Detergent extracted
OMV vaccines have been successfully used for clonal
outbreaks of meningococcal B disease (Martin et al.,
1998; Dyet and Martin, 2005) but do not induce broad
serogroup B coverage since the predominant bactericidal
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antibody response is against the major membrane protein
PorA, which has high antigenic variability. It is also
thought that the process of detergent extraction to remove
LOS results in depletion of lipoproteins that could be to
be important for generating cross protective antibody
responses. An alternative to detergent extracted OMVs is
native outer membrane vesicles (NOMV), which are
extracted without the use of a detergent, so LOS remains
in the cell membrane along with outer membrane lipopro-
teins. NOMV with wild-type lipid A would be too toxic for
human use, therefore one strategy has been to engineer
Nm that express LOS with pentacylated lipid A (lpxL1)
which shows reduced endotoxin activity than wild-type
LOS (Fisseha et al., 2005). lpxL1 NOMVs are in fact
currently being investigated as potential meningococcal
vaccines (Keiser et al., 2010; Koeberling et al., 2011).
Interestingly lpxL1 lipid A variants are found naturally
and appear to be associated with a less severe
meningococcal disease (Fransen et al., 2009; Rodenburg
et al., 2012).
While the identification of the most appropriate vaccine
antigens that confers broad coverage of serogroup
B strains is important, the way in which these
meningococcal antigens are presented in a vaccine could
also be critical for the generation of effective immunity.
NOMV provide a potential delivery system for multiple
epitopes presented in their native conformation. In order
to further aid antigen delivery it is also possible to target
vaccine components to antigen presenting cells, particu-
larly dendritic cells (DC) (Tacken and Figdor, 2011; Ueno
et al., 2011). DC are professional antigen presenting cells
that are critical for the induction of protective immunity
(Banchereau et al., 2000). Immature DC are highly
phagocytic and express an array of pattern recognition
receptors (Takeuchi and Akira, 2010), which stimulates
the process of DC maturation and initiates the stimulation
of naïve T-cells and shapes the nature of adaptive
immune response. For these reasons, DC have been
considered an ideal target for vaccine antigens. One
receptor that is expressed abundantly by DC of the
lymphoid tissues and mucosal surfaces is dendritic
cell-specific intercellular adhesion molecule-3-grabbing
non-integrin (DC-SIGN) (Geijtenbeek et al., 2000;
Soilleux et al., 2002). Our group and colleagues have
shown that LOS structure can be modified by deletion of
the lgtB gene revealing a structural motif that is specifi-
cally recognized by DC-SIGN (Steeghs et al., 2006). Fur-
thermore, Nm expressing the lgtB LOS oligosaccharide
modification are more readily phagocytosed by human
DC than their wild-type strain predominately via DC-SIGN
(Steeghs et al., 2006).
Despite the fact that a number of effective vaccines
have been shown to be potent stimulators of DC in vitro
(Querec et al., 2006; Agrawal et al., 2009), there are few
studies that have investigated how OMVs vaccines inter-
act with DC (Mesa et al., 2004; Rodriguez et al., 2005;
Schultz et al., 2007). In this study, we investigated
the interaction of meningococcal NOMV with human
monocyte-derived DC to further understand the biological
activity of NOMV in host immune interactions. We also
prepared NOMV from a novel meningococcal mutant that
lacks capsule (siaD), to avoid potential autoreactivity,
expresses LOS with a pentacylated lipid A that displays
reduced toxicity (lpxL1) and a truncated oligosaccharide
(lgtB) that can target DC-SIGN on DC. By evaluating the
induction DC maturation, phagocytic uptake, DC cytokine
induction and T-cell stimulation we provide evidence that
such a strategy could be used to generate a novel vaccine
delivery system to protect against serogroup B men-
ingococcal disease.
Results
NOMV from LOS modified strains of N. meningitidis
induce distinct expression patterns of maturation
receptors on the surface of DC
Human DC were stimulated with NOMV from the LOS
modified strains and surface expression of HLA-Class I,
HLA-DR, CD40 and CD83 were determined by Flow
Cytometry. An increase in the expression of all molecules
examined was observed upon stimulation with lgtB NOMV
when compared to unstimulated DC (Fig. 1). These were
similar levels to those expected from either purified LOS
or killed Nm whole bacteria. Similar expression levels
were also observed with NOMV from unencapsulated
wild-type bacteria (data not shown). The lpxL1 NOMV with
a pentacylated lipid A induced modest expression of
CD40 compared to unstimulated but induced little to no
expression of HLA-Class I and HLA-DR and CD83. This
finding is consistent with reduced inflammatory potential
of lpxL1 lipid A compared to its hexacylated wild-type
lipid A counterpart. However, the combination of a
pentacylated lipid A and DC-SIGN recognition motif
(lpxL1/lgtB) significantly increased the expression levels
for CD40 (P = 0.05), HLA-DR (P = 0.009) and HLA-Class
I (P = 0.004), but not CD83, when compared to those
observed for the NOMV derived from the single lpxL1
mutation. This finding demonstrates enhanced expression
of certain surface markers through the engagement of
DC-SIGN in the presence of a lpxL1 mutation.
LOS structure critically influences uptake of NOMV
by DC
lgtB modified Nm are more readily phagocytosed than Nm
expressing wild-type LOS (Steeghs et al., 2006). One
potential advantage of using lgtB modified NOMV is to
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Fig. 1. Dendritic cell surface phenotype following stimulation with LOS modified NOMV. Human monocyte-derived DC were stimulated with
1 μg ml−1 NOMV for 18–24 h and then analysed by Flow Cytometry for the expression of surface proteins CD40, HLA-DR, HLA-Class I and
CD83. Data from one representative donor are shown (A) together with a summary of data from eight individual human donors (B). Data are
expressed as the mean and standard error of the mean and significance was determined by a paired t-test.
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increase uptake of meningococcal antigens to DC.
Human DC were co-cultured with FITC-labelled LOS-
modified NOMV and uptake measured by flow cytometry.
As shown in Fig. 2A and B, the lgtB NOMV were most
readily internalized by DC. In contrast, no obvious uptake
was observed for the lpxL1 NOMV even when NOMV
concentrations were increased beyond 10 μg ml−1. Inter-
estingly, the lpxL1/lgtB NOMV were taken up by DC but
not to the same extent as those observed for lgtB NOMV.
More surprisingly, NOMV from unencapsulated Nm with
wild-type (WT) LOS (H44/76 SiaD) were not taken up by
DC, displaying a very similar pattern as seen for lpxL1
NOMV. These data strongly suggest that majority of
phagocytosis is via interaction with DC-SIGN. In order to
Fig. 2. Internalization of LOS modified NOMV by dendritic cells. Human monocyte-derived DC were co-cultured with 10 μg ml−1 FITC labelled
NOMV for 4 h. DC were separated into 3 aliquots to distinguish internalized and surface adhered NOMV. One aliquot was left untreated and
the second was treated with 0.4% trypan blue to quench FITC signal emitted from extracellular NOMVs. DC were then analysed by flow
cytometry. The third aliquot was stained with To-Pro3 (blue) to stain the nucleus and anti-meningococcal serosubtype P1.7 antibody followed
by Alex Fluor 568 goat anti-mouse to stain the surface adhered NOMV. Cells were then analysed by Confocal Microscopy. Data are shown
from one representative donor (A and C) together with the summary of data from eight donors (B). Data are expressed as the mean and
standard error of the mean and significance was determined by a paired t-test.
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confirm further that NOMV were internalized we used a
differential antibody staining and confocal microscopy
method to distinguish NOMV which were either surface
bound and internalized by DC. As Fig. 2C shows, both
lgtB and lpxL1/lgtB NOMV are internalized, while lpxL1
and WT NOMV were only found on the surface, thus
confirming flow cytometric observations.
We next examined the levels of phagocytosis in
the presence of both DC-SIGN blocking antibody and
N-acetyl glucosamine (GlcNAc), which have been previ-
ously shown to block the interaction between DC-SIGN
and lgtB expressing Nm (Steeghs et al., 2006). Whole
N. meningitidis bacteria expressing wild-type LOS were
included as a control as its uptake is independent of
DC-SIGN. As Fig. 3 shows the uptake of lgtB and lpxL1/
lgtB expressing NOMV were reduced in the presence
of DC-SIGN receptor blockers. Uptake was not com-
pletely prevented as a small percentage of cells were still
Fig. 3. Effect of DC-SIGN blocking antibody and GlcNAc on internalization of LOS modified NOMV. Human monocyte-derived DC were
stimulated with 10 μg ml−1 FITC-labelled NOMV for 4 h in the presence of either 20 μg ml−1 DC-SIGN blocking antibody or 50 mM N-acetyl
glucosamine. DCs were then treated with 0.4% trypan blue to quench any FITC signal from surface bound NOMV. Data are representative of
three experiments from three different donors yielding similar results.
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positive for FITC although it is important to note that
complete blocking of DC-SIGN even with high antibody
concentrations can be difficult as DC-SIGN is so highly
expressed on human monocyte derived DC. As expected,
no effect of DC-SIGN blocking antibody or N-acetyl
glucosamine was observed for the uptake of lpxL1 NOMV
(Fig. 3) or whole bacteria expressing wild-type LOS.
Taken together, this shows that the majority uptake of
NOMV containing lgtB LOS, whether on wild-type or lpxL1
lipid A background, is via the receptor DC-SIGN.
NOMV from LOS modified Nm modulates DC
cytokine production
Wild-type LOS is a potent stimulator of innate cells induc-
ing a robust pro-inflammatory cytokine response, which is
the major reason why DOMV, which have dramatically
reduced LOS content, have been used in currently
licensed vaccines. The rationale for using an lpxL1 modi-
fied NOMV is to prevent a pronounced inflammatory host
response, which could lead to excessive inflammation
and toxicity. However, there are few data that are avail-
able on the effect of lpxL1 expressing NOMV on host
inflammatory responses, specifically in DCs. DCs were
stimulated with LOS-modified NOMV for 18 h, and then
supernatant from these cells was collected and analysed
by ELISA for TNF-α, IL-6 and IL-1β production. As Fig. 4
shows lgtB NOMV induced the greatest amount of inflam-
matory cytokine production from DC, significantly more
than those observed for NOMV from an unencapsulated
wild-type bacteria (IL-1β, P = 0.008; IL-6, P = 0.03;
TNF-α, P = 0.008). However, consistent with the reduced
pro-inflammatory capacity of lpxL1 LOS, both lgtB/lpxL1
and lpxL1 NOMV induced significantly reduced cytokine
production compared to lgtB NOMV (P = 0.008). Notably,
inflammatory cytokine levels in response to DOMV iso-
lated from wild-type Nm were in a similar range to those
induced by NOMV with pentacylated lipid A lpxL1 (data
not shown) despite of the fivefold higher LOS content of
the latter.
We then investigated whether LOS modification of
NOMV influenced the production of T-cell stimulatory
cytokines IL-12, IL-10, IL-23 and also Prostaglandin E2
(PGE2) by DC. Since we have previously shown that
uptake of whole wild-type bacteria is required for the
production of both IL-10 and IL-12p70 by human DC
(Jones et al., 2007), we hypothesized that the observed
differences in uptake between the LOS modified NOMV
may have a similar effect on production of IL-10 and
IL-12p70. As Fig. 5 shows, IL-12p70 production by DC
was detected in response to lgtB NOMV however no IL-12
was induced by either NOMV preparations expressing
lpxL1 pentacylated lipid A. In contrast, all NOMV prepa-
rations induced IL-10, IL-23 and PGE2 production, but
pg
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Fig. 4. The production of inflammatory cytokines by DC in
response to LOS modified NOMV. Human monocyte-derived DC
were stimulated with 1 μg ml−1 LOS modified NOMV for 18–24 h.
Supernatants were collected and then analysed for the presence of
inflammatory cytokines TNF-α, IL-1β, IL-6, by ELISA. A summary of
data is shown for 8 human donors. Data are expressed as the
mean and standard error of the mean. Statistical significance was
tested using a paired t-test.
524 H. E. Jones et al.
© 2013 The Authors. Cellular Microbiology published by John Wiley & Sons Ltd, Cellular Microbiology, 16, 519–534
significant reduction in levels were observed for NOMV
with a pentacylated lipid A (Fig. 5: IL-10 P = 0.0005; IL-23
P = 0.008; PGE2 P = 0.03). Despite the significant reduc-
tion in IL-10 and IL-23 levels in DC stimulated with
pentacylated lipid A compared to NOMV expressing wild-
type lipid A, IL-10 production was still produced in the
range of 6000–500 ng ml−1 and IL-23 500–50 ng ml−1
depending on donor. Moreover, for IL-10 and IL-23, a
significant, albeit small increase in cytokine levels was
found for the lpxL1/lgtB NOMV compared to lpxL1 NOMV
(IL-10 P = 0.001; IL-23 P = 0.008) suggesting that lgtB
modification on pentacylated background itself can
enhance IL-10 and IL-23 production in DC (Fig. 5). There
was no significant difference in the levels of PGE2 and
IL-12 production induced by WT and lgtB NOMV;
however, a significant reduction of IL-23 and IL-10 pro-
duction was observed for WT NOMV (IL-10 P = 0.0391;
IL-23 P = 0.0078) compared to lgtB NOMV.
We have previously shown that phagocytosis of whole
Nm is indispensible for both IL-10 and IL-12 p70 produc-
tion by DC (Jones et al., 2007), we therefore next inves-
tigated whether the uptake of NOMV also influenced
cytokine production. DC were co-cultured with NOMV in
the presence of the phagocytosis inhibitor cytochalasin
D. As Fig. 6 shows, phagocytic uptake of NOMV also
appears to be indispensible for the production IL-10 and
IL-12p70 as the inclusion of cytochalasin D almost com-
pletely abrogated cytokine production of these cytokines.
Interestingly, the effect of blocking phagocytosis on IL-23
production was only partial, with IL-23 levels being
reduced by more than 50%. In contrast, cytochalasin
D had a minimal effect on TNF-α, IL-1β and IL-6
Fig. 5. The production of T-cell polarizing
cytokines by DC upon stimulation with LOS
modified NOMV. Human monocyte-derived
DC were stimulated with 1 μg ml−1 LOS
modified NOMV for 18–24 h. Supernatants
were collected and then analysed for the
presence T-cell polarizing cytokines IL-10 (A),
IL-23 (B), IL-12p70 (C) and PGE2 (D) by
ELISA. A summary of data is shown for eight
human donors. Data are expressed as the
mean and standard error of the mean.
Statistical significance was tested using a
paired t-test.
Dendritic cell responses to meningococcal vesicles 525
© 2013 The Authors. Cellular Microbiology published by John Wiley & Sons Ltd, Cellular Microbiology, 16, 519–534
production (data no shown) suggesting no major role for
phagocytosis for induction of these cytokines, consistent
with what we have demonstrated previously for whole
bacterial interactions with human DC (Uronen-Hansson
et al., 2004).
Induction of CD4+ T helper responses by NOMV
stimulated DC
We next wanted to establish what, if any, functional
consequence these differences in DC phenotype and
cytokine profiles had on capacity to stimulate T-cells. We
were particularly concerned to establish whether targeting
NOMV via DC-SIGN could cause excessive skewing of
naive T-cells towards a Th1 or Th2 phenotype. In the case
of DC-SIGN engagement, this can often give contrasting
immune effects depending on ligand, in some cases it can
drive effector T-cells whereas in other instances specific
pathogens use it for immune evasion (Zhou et al., 2006).
Using an established DC and naïve CD4+ T-cell in vitro
model system (de Jong et al., 2002), DC were stimulated
with NOMV for 24 h and then co-cultured with naïve
CD4+ T-cells for 12 days in the presence of IL-2 and SEB
(Fig. 7). The proportion of Th1 and Th2 cells were identi-
fied by the expression of IFN-γ and IL-4 respectively. DC
and T-cells co-cultures from nine individual donors were
analysed for the presence IL-4 and IFN-γ producing
T-cells by Flow Cytometry. All NOMV induced IFN-γ- and
IL-4-producing cells to a similar magnitude to Th1 (Poly
IC) and Th2 (Cholera Toxin) positive controls. As Fig. 7
shows, there were some observed differences in median
percentage positive naïve CD4 cells producing Th1
cytokine IFN-γ, with lpxL1/lgtB pulsed DC promoting the
greatest and the wild-type NOMV the least. As far as
promoting Th2 polarized IL-4-producing cells, the lgtB
NOMV pulsed DC promoted the most and the wild-type
the least. However, these difference were not found to be
significantly different (Friedman sign ranks test IFN-γ
P = 0.57; IL-4 P = 0.97). Taken together, these data
suggest that the lgtB LOS, whether with wild-type or
pentacylated lipid A, does not promote significant skewing
of naïve T-cells by DC.
Human DCs are also known to promote the expansion
of Th17 cells from memory T-cells (van Beelen et al.,
2007), and Th17 responses have been shown to be
important for protection against mucosal pathogens by
stimulating the production of anti-microbial peptides and
the recruitment of neutrophils (McAleer and Kolls, 2011).
Considering the role of IL-23 in promoting the expansion
of Th17 cells from human memory CD4+ T-cells and the
differential expression of IL-23 by DC in response to the
NOMV we hypothesized that this could affect the genera-
tion of Th17 cells. NOMV stimulated DC were co-cultured
with memory CD4+ T-cells for 5 days and then assessed
for IL-17 production by flow cytometry (Fig. 7). Low per-
centages of IL-17 producing T-cells were detected;
however, these are similar levels to those observed in the
literature (Truchetet et al., 2011). Despite small differ-
ences in percentage between the groups there was a
significant difference (Friedman test P = 0.0239). lgtB
Fig. 6. The effect of blocking phagocytosis of NOMV on DC
cytokine production. Human monocyte-derived DC were co-cultured
with 1 μg ml−1 NOMV in the presence of 10 μg ml−1 cytochalasin D
(cytD) for 18–24 h. Supernatant was collected and analysed for
IL-10, IL-12p70 and IL-23 production. Data from one representative
donor out of three are shown.
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NOMV stimulated DC promoting the greatest percentage
of IL-17 producing T-cells, with lpxL1 NOMV stimulated
DC promoting the least. These data suggest that the
differential capacity of NOMV to stimulate IL-23 by DC
production could be responsible for the capacity of DC
pulsed with NOMV preparations to influence promotion of
Th17 cells from memory T-cells.
Immunogenicity of NOMV from LOS modified Nm in a
murine in vivo model
While we have shown in vitro in human cells that lpxL1
and lpxL1/lgtB induced significant differences in antigen
internalization and the expression of specific cytokines
and maturation molecules in human DC, it is unknown
how this may effect the immunogenicity of the LOS-
modified NOMV in vivo. To gain some initial immuno-
genicity data of the modified NOMV, mice were
immunized with 5 μg of lgtB, lpxL1, lpxL1/lgtB on days 0,
14 and 28 and then serum was analysed for antibody by
whole Nm ELISA and serum bactericidal assay (SBA) at
day 42. All mice produced specific IgG to wild-type H44/76
Nm in response to the NOMV (Fig. 8A) and this was
shown to have SBA against wild-type H44/76. However,
there was a significant reduction in the IgG levels
(P = 0.006, P = 0.0014) and serum bactericidal activity
(P = 0.0009, P = 0.03) in mice that were immunized with
NOMV containing lpxL1 modification. No difference was
observed between lpxL1/lgtB and lpxL1 NOMV.
The antibody response to Nm is predominantly directed
against the outer membrane protein, PorA (Martin et al.,
2006), which is antigenically variable and results in a strain-
specific response to Nm. We therefore wanted to determine
if there was antibody to proteins other than PorA. For this
we used PorA-deficient H44/76 bacteria for ELISA and SBA
assays. There was a log reduction in IgG titres against the
PorA-negative strain compared to wild-type H44/76 for all
NOMV immunized. There was a significant difference
between IgG titre generated in response to lgtB compared
to lpxL1 (P = 0.03), but no significant difference was
observed between lpxL1 and lpxL1/lgtB. For SBA against
PorA-deficient H44/76 significant differences were detected
by Fishers Exact Test as not all mice responded in this
assay (lgtB 8/15 responders; lpxL1/lgtB 8/15 responders;
lpxL1 4/15 responders). No significant differences were
Fig. 7. The effect of NOMV stimulated DC on Th1, Th2 and Th17
responses. To assess the generation of Th1 and Th2 responses
naïve CD4+ T-cells were co-cultured with NOMV-stimulated DCs
(1 μg ml−1 for 18–24 h) for 12 days in the presence of IL-2 and
100 pg ml−1 SEB. On the 12th day T-cells were restimulated with
10 ng ml−1 PMA and 1 μg ml−1 ionomycin for 5 h, cells were then
analysed by flow cytometry for the production of IFN-γ and IL-4
(Th1 and Th2 skewing cytokines respectively). To assess Th17 cell
responses NOMV-stimulated DC (1 μg ml−1 for 18–24 h) were
co-cultured with memory CD4+ cells for 5 days in the presence of
IL-2 and SEB. T-cells were then stimulated with PMA and
ionomycin and then analysed by flow cytometry for IL-17
production. Each point on the graph represents each separate
donor and the mean of each group is also shown. Statistical
significance was determined by a Friedman test. Significant
differences are indicated on the figure.
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observed between the groups; however, it is interesting to
note the 8 responders in the lpxL1/lgtB group compared 4 in
the lpxL1 immunized group.
Discussion
Targeting of vaccine components directly to DC has
been considered an effective strategy for many years
(Tacken and Figdor, 2011). In this study we have utilized
the modified meningococcal lgtB LOS which binds to
DC-SIGN (Steeghs et al., 2006), together with lpxL1
LOS modification to limit endotoxin toxicity. Lpxl1 NOMV
are actively being considered as vaccines against
meningococcal disease (van der Ley and van den
Dobbelsteen, 2011), we therefore wanted to understand
how a further lgtB modification may impact on human in
vitro DC and T-cell responses. We have shown that the
addition of a lgtB modification to a pentacylated lipid A
NOMV significantly increases the upregulation of CD40,
HLA-Class and HLA-DR, but does not appear to affect
the reduced pro-inflammatory effect of the lpxL1 lipid A
compared to wild-type lipid A. Moreover, the addition
of lgtB moiety appears to be critical for targeting
meningococcal antigens for uptake by DC. Small, but
significant differences in DC IL-23 levels also correlated
with IL-17 production from memory T-cells. However
despite differences in IL-10 and IL-12 production, lgtB
binding to DC-SIGN had no major impact on the Th1
and Th2 cell polarization.
The diminished levels of DC maturation by
pentacylated lipid A expressing NOMV, is consistent with
previous findings that show lpxL1 LPS to be a poor stimu-
lator of TLR4 (Steeghs et al., 2008). However the addition
of lgtB mutation resulted in a significant increase in
expression of CD40, HLA-DR and HLA-Class 1 compared
to lpxL1 expressing NOMV. This shows that lgtB modifi-
cation can augment the weak stimulatory capacity of
lpxL1 LOS, and also suggests that targeting DC-SIGN is
involved in this effect. This could be a significant obser-
vation as DC-SIGN engagement in some situations can
suppress DC maturation (Mittal et al., 2009).
Surprisingly neither the wild-type or lpxL1 NOMV were
internalized by DC, despite earlier studies showing that
both wild-type and lpxL1 whole bacteria can be internal-
ized by DC (Uronen-Hansson et al., 2004; Steeghs et al.,
2008). The addition of a lgtB mutation has a marked effect
on NOMV uptake, even in the presence of an lpxL1 muta-
tion. A number of receptors have been identified for the
internalization of whole Nm (Peiser et al., 2002; Jones
et al., 2003; 2008; Schmitt et al., 2009), but DC-SIGN
appears to be the major receptor involved in uptake of
NOMV into monocyte derived DC. The NOMV is repre-
Fig. 8. The immunogenicity of NOMV in a
murine in vivo model. BALB/c mice (15 per
group) were immunized with 5 μg of lgtB,
lpxL1/lgtB or lpxL1. Serum was collected at
day 42 and analysed for specific IgG antibody
by ELISA (A). Wild-type H44/76 and
PorA-deficient H44/76 were used as target
antigens in the ELISA. Specific IgG levels are
expressed as log10 titres for individual mice
and the geometric mean is shown for each
group. Antibody function was assessed by
SBA (B). Briefly, mouse serum was incubated
with rabbit complement together with either
wild-type H44/76 or PorA-deficient H44/76.
Highest dilution that resulted in 90% killing of
bacteria is shown for individual mice and the
geometric mean for each group. Statistical
significance was determined by a paired
T-test unless stated otherwise. For SBA
against PorA-deficient H44/76 the number of
responders are indicated on the graph. A
responder was defined as a mouse that who
serum killed 90% of bacteria at at least 1:5
dilution. *Statistical significance was
determined by Fishers Exact Test.
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sentative of the outer membrane of the bacteria, but the
major difference is the size of the particle. NOMV are less
than 150 nm and particles of this size are generally inter-
nalized via clathrin-mediated endocytosis (Xiang et al.,
2006). Interestingly, it has been shown that DC-SIGN
internalization through targeting of the carbohydrate rec-
ognition domain occurs via clathrin-coated pits which may
go some way to explain why the majority of NOMV uptake
was via DC-SIGN (Cambi et al., 2009).
The lpxL1/lgtB NOMV were not taken up by DC to the
same extent as lgtB NOMV suggesting that lipid A struc-
ture is important for maximal NOMV internalization. All
NOMV expressed similar levels of LOS on the surface
and a monoclonal antibody to lgtB showed there to be no
structural differences between lgtB and lpxL1/lgtB NOMV.
However, meningococci expressing lpxL1 LOS are more
susceptible to antibiotics, which may suggest that the
outer membrane barrier may be compromised (van der
Ley et al., 2001) and it is tempting to suggest that this may
have some effect on how LOS is presented in the bacte-
rial outer membrane. This could affect how accessory
proteins such as CD14, lipopolysaccharide-binding
protein and bactericidal/permeability-increasing protein
(BPI), known to be involved in LOS recognition, bind to
the LOS. Interestingly BPI was shown to enhance uptake
of NOMV expressing wild-type LOS by DC (Schultz et al.,
2007). Another possible explanation for the reduced
uptake of lpxL1/lgtB compared to lgtB NOMV may be the
reduced TLR4 engagement of lpxL1/lgtB LOS. It is pos-
sible that TLR4 engagement enhances uptake of NOMV
through a positive feedback loop.
Regardless of the observed differences between the
lpxL1 and lpxL1/lgtB NOMV in terms of DC internalization
and maturation, similar pro-inflammatory cytokines
TNF-α, IL-1β and IL-6 were observed for both these
stimuli. Moreover, the levels of pro-inflammatory cytokines
observed for lpxL1 containing NOMV were similar of a
similar magnitude to those induced by DOMV from wild-
type bacteria, which are currently used for meningococcal
outbreaks (data not shown). This is important as absence
of excessive local and systemic inflammation is a require-
ment for safe vaccines, consistent with studies that have
shown a clear correlation between cytokine production
and vaccine reactogenicity (Gaines Das et al., 2004).
The finding that diminished levels of IL-10, and IL-23
and no IL-12p70 were produced by DC stimulated with
lpxL1 and lpxL1/lgtB NOMV compared to lgtB NOMV is
perhaps not surprising as lpxL1 LOS poorly activates
human TLR4 (Steeghs et al., 2008) and that the role of
TLRs in the production T-cell stimulatory cytokines IL-10,
IL-12p70 and IL-23 is well established (Medzhitov et al.,
1997; Rescigno et al., 1998). The level of cytokine pro-
duction strongly correlates with the amount of NOMV
internalization implying that receptor engagement within
the DC is likely to be critical. Receptors such as TLR2,
TLR4 and NOD-2, which are all implicated in IL-10,
IL-12p70 and IL-23 production, are known to expressed
within human monocyte-derived DC (Uronen-Hansson
et al., 2004; van Beelen et al., 2007). Despite the reduc-
tion in levels of IL-10 and IL-23 induced by lpxL1 contain-
ing NOMV compared to those with hexacylated LOS, the
addition of lgtB modification on the lpxL1 background
significantly increased production of both these cytokines
by DC.
There have been relatively few comprehensive studies
on T helper cell responses to meningococci. One study
demonstrated an unbiased T helper cell polarization in
response to meningococci carriage (Robinson et al.,
2002). It is likely that both Th1 and Th2 responses are
important for generating immunity to meningococcus or
vaccine components. Th2 is often associated with pres-
ence of IL-10 (produced by DC for example) which
is important for B cell isotype switching, while Th1
responses promote production of antibody isotypes
IgG2a and IgG2b which are known to be important for
meningococci complement mediated killing (Hoogerhout
et al., 1995; de Kleijn et al., 2001).
Since DC have a unique role in polarizing naïve T
helper cells and for this reason we felt that examining the
ability of NOMV pulsed DC to influence this polarization
informative. Our data show that, despite differences in
PGE2 (Th2), IL-10 (Th2) and IL-12 (Th1) production and
the reduced expression of maturation markers by DC, all
NOMV stimulated DC induced similar ratios of Th1 and
Th2 cells in vitro. Interestingly, the complete abrogation of
IL-12 production by lpxL1 stimulated DC had no effect on
Th1 the response. However, this finding may not be all
that unexpected since other cytokines such as IL-18 and
Type 1 Interferons (Sareneva et al., 1998) are involved in
Th1 responses. However the lack of an unbiased polari-
zation towards Th1 and Th2 does show that DC-SIGN and
lgtB engagement in this instance does not have a major
effect on T-cell polarization. This could be of interest and
potential significance, as DC-SIGN engagement can
result in tolerogenic DC phenotype (Mittal et al., 2009) a
finding that we believe to be important preliminary data in
justifying its use in human volunteers.
We observed significant, albeit small difference in the
expansion of memory Th17 cells in response to the lpxL1/
lgtB and lpxL1 pulsed DC. All the NOMV stimulated DC
production of IL-1β, IL-6 and IL-23, which have all been
implicated in Th17 cell differentiation (van Beelen et al.,
2007). However, IL-23 levels in DC did appear to correlate
with the percentage of Th17 cells, with lpxL1 NOMV
inducing the least IL-23 production and the least percent-
age of Th17 cells. It is not known at present how this could
influence vaccine responses, but the capacity of lgtB/
lpxL1 NOMV to induce Th17 cells may be advantageous.
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Th17 cells play a key role in the induction of mucosal
inflammation and host protection against extracellular
pathogens (van Beelen et al., 2007), moreover, IL-17 is
involved in the recruitment of neutrophils, which is impor-
tant for host defence against meningococci (Bettelli et al.,
2008; Peck and Mellins, 2010).
The murine data presented here show that, as might be
expected, presence of the wild-type LOS with the lgtB
modification significantly enhances specific antibody pro-
duction and SBA to the homologous strain in both a porA-
dependent and a porA-independent manner compared to
responses to lpxL1 expressing NOMV. The likely reason
for this is the greater adjuvant effect of hexacylated LOS.
We considered it plausible that the difference in DC
co-stimulation induced by lpxL1/lgtB compared to the
lpxL1 NOMV might be reflected in capacity to influence
antibody production and SBA. There was some sugges-
tion from the SBA data from a PorA-deficient Nm that
there was an increased number of responders in those
mice immunized with lpxL1/lgtB (8/15) compared to lpxL1
(4/15). However, this was not a significant difference, and
therefore the activity of the two NOMV are equivalent in
this model. Although we believe these to be useful and
important data to include, we feel this should be inter-
preted with caution with regard to predicting the likely
effect in humans. The mice commonly used for in vivo
immunogenicity studies do not express an orthologue of
DC-SIGN, so the effects of lgtB mutation may not be fully
apparent in murine studies. Human DC-SIGN transgenic
mice are available; however, the use of these mice in
vaccination studies may not recapitulate the biology of
DC-SIGN in humans (Garcia-Vallejo and van Kooyk,
2013).
We believe that the addition of the lgtB moiety to lpxL1
requires further consideration and the only way to ascer-
tain its effects in vivo is to use healthy human volunteers.
As the lgtB modification is essential for internalization of
meningococcal NOMV, it is tempting to speculate that this
could influence meningococcal-specific immunity induced
by these vaccines. It is known that efficiency of uptake of
antigen by DC, as well as co-stimulatory signals derived
from adjuvant factors, is an important determinant of gen-
eration of antigen-specific immunity.
A major attraction of using NOMV is that they contain
multiple meningococcal antigens in native conformation.
These could be modified further to express antigens
of interest, for example non-binding factor H binding
mutants, plus other targets to cover invasive disease
caused by Nm strains that do not express fHbp, which has
been one of the major vaccine antigens considered over
the last few years (Lucidarme et al., 2011). We propose
that additional modification of the LOS to include a
DC-SIGN targeting motif would increase antigen delivery
to DC, with better T-cell co-stimulation than lpxL1
preparations and has potential to enhance cross protec-
tion against serogroup B.
Experimental procedures
All reagents were obtained from Sigma-Aldrich unless otherwise
stated.
Ethics statement
Blood samples were collected from healthy laboratory volunteers
with written informed consent. The Institute of Child Health
Human Tissue Act Review Board approves the use of blood in
this study, from healthy adults volunteers. Consent and donations
were recorded in accordance the Institute of Child Health’s
Research Governance and Ethical Regulations.
Genetic modification of N. meningitidis strain
All genetically modified strains used in this study were derived
from wild-type group B N. meningitidis H44/76 (Holten, 1979).
The unencapsulated (siaD) lpxL1, lgtB and lpxL1/lgtB and
PorA mutants were constructed by insertional deletion of the
capsulation gene siaD and LOS biosynthesis genes lpxL1 and
lgtB. All modified strains were characterized by SDS-PAGE to
confirm no major differences in surface protein and LOS expres-
sion. LOS structure for each of the modified strains was con-
firmed using mass spectrometry and monoclonal antibodies
specific to the oligosaccharide part of the LOS. NOMV from
unencapsulated siaD bacteria are defined in this study as wild-
type NOMV. All other NOMV from LOS modified strains are
defined by the modified gene, lpxL1, lgtB and lpxL1/lgtB.
Isolation and characterization of native outer
membrane vesicles
Bacteria were grown overnight in Tryptic Soy Broth (Oxoid) and
then pelleted by centrifugation. Bacterial pellet was suspended in
0.1 M Tris, 0.01 M EDTA pH 8.6 and agitated for 1 h to encourage
release of vesicles into the supernatant. Vesicles were collected
from supernatant by ultracentrifugation (150 000 g for 1 h) and
then washed with 0.05 M Tris, 2 mM EDTA, 3% sucrose pH 8.9.
NOMV were then resuspended in 0.01 M Tris pH 7.4, 3%
sucrose, 0.01% thimerosal and then stored at 4°C until required.
Protein content of NOMV preparations was determined using a
BCA assay (Thermo Scientific) and LOS content was assessed
using SDS-PAGE analysis. All NOMV concentrations used in this
study are based on protein content.
For phagocytosis experiments NOMV were labelled with
0.5 mg ml−1 Fluorescein isothiocyanate (FITC) for 30 min at
37°C. NOMV were then washed with PBS to remove excess
FITC and collected by ultracentrifugation (150 000 g for 1 h).
FITC incorporation into the NOMV was verified by flow cytometry
using a FACScalibur (BD Biosciences). No major changes in the
size or density of the vesicles following FITC labelling were
observed. In optimization experiments, FITC-labelled NOMV also
gave similar maturation and cytokine responses in DCs to unla-
belled NOMV.
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Human monocyte derived dendritic cell culture
DC were generated from monocytes as previously described
(Sallusto and Lanzavecchia, 1994; Dixon et al., 2001). Briefly,
monocytes were isolated from peripheral blood mononuclear
cells (PBMC) using CD14 immunomagnetic bead separation
technology (Miltenyi Biotec, Surrey, UK). CD14-positive cells
were cultured for 5–7 days in RPMI with 10% fetal calf serum,
2.4 mM L-glutamine, 100 U ml−1 penicillin, 100 mg ml−1 strepto-
mycin (all Invitrogen), 100 ng ml−1 GM-CSF and 50 ng ml−1 IL-4
(R&D systems). Immature DC were DC-SIGN-positive, CD3-
negative, CD19-negative, CD25-negative and expressed low
levels of HLA-DR, HLA-Class I, CD40, CD83, CD86 and CD1.
Internalization assay
DC (5 × 105 ml−1) were co-cultured with 10 μg ml−1 FITC-labelled
NOMV for 4 h so to maximize visualization of NOMV uptake. In
some experiments 20 μg ml−1 of DC-SIGN blocking antibody
[R&D systems (clone 120507)] or 50 mM N-acetyl glucosamine
was included to block receptor DC-SIGN. Complete blocking
of phagocytosis was achieved by the addition of 10 μg ml−1
cytochalasin D, an actin polymerization inhibitor. After 4 h, DC
were incubated for 10 min with 0.4% trypan blue to quench FITC
signal from extracellular NOMV. DC were then washed twice with
FACs buffer (PBS with 0.2% bovine serum albumin and 0.02%
sodium azide) and then fixed with 4% paraformaldehyde. Cells
were then analysed by flow cytometry using a FACScalibur (BD
Biosciences). The DC population was defined by forward and
side scatter profile and at least 5000 events were collected in this
gate. NOMV uptake was defined as the proportion of cells in the
DC population that were positive for FITC expression. Data were
analysed by FlowJo software.
For confocal microscopy analysis DC were washed with PBS
following a 4 h period of FITC-NOMV stimulation and allowed to
adhere to adhesion slides for 10 min (Paul Marienfeld Gmbh and
CO, Germany). Cells were then fixed with 4% paraformaldehyde.
To distinguish between surface bound and internalized NOMV,
surface bound NOMV were stained with 10 mg ml−1 P1.7 anti-
bodies specific for Nm (NIBSC, South DCs) followed by Alexa
Fluor 568 goat anti-mouse IgG (Life Technologies, UK). DC were
visualized by staining the nuclei with To-Pro3 (Molecular Probes,
Cambridge Biosciences, Cambridge, UK). Slides were then
washed and mounted with SlowFade Gold (Life Technologies,
UK) and then images were obtained using a Zeiss Confocal
Laser Scanning Microscope 710. To identify internalized bacteria
at least 10 optical sections (0.2–0.5 mm) spanning the entire DC
were visualized by open source software program Fiji (http://
fiji.sc/Fiji).
DC surface marker expression and cytokine detection
Immature DC (5 × 105 ml−1) were co-cultured with 1 μg ml−1
NOMV for 18–24 h. Cells were harvested in FACs buffer and then
labelled with FITC- or phycoerythrin (PE)-conjugated monoclonal
antibodies (2 μg ml−1) to CD40, CD83, HLA-DR and HLA-Class I
(Invitrogen) for 30 min at 4°C. Cells were then washed with
FACs buffer and fixed with 4% paraformaldehyde. Cells were
then analysed by flow cytometry using a FACScalibur (BD
Biosciences).
DC supernatants were removed following 24 h stimulation
with NOMV and then analysed for the presence of TNF-α,
IL-1β, IL-6, IL-10, IL-12p70, IL-10 (eBioscience) and PGE2
(GE Healthcare, UK) by ELISA according to manufacturer’s
instructions.
DC polarization of T helper responses
Naïve CD4+ T-cell Th1 and Th2 polarization was carried out as
previously described (de Jong et al., 2002). First, DC were
stimulated with 1 μg ml−1 NOMV, 20 μg ml−1 Poly I:C (Th1
skewing positive control), and 10 μg ml−1 Cholera toxin (Th2
skewing positive control) for 24 h. Cells were than washed and
counted. Naïve CD4+ T-cell were isolated from PBMCs using a
Naïve CD4+ T-cell isolation kit (Miltenyi Biotec) and subse-
quently co-cultured with stimulated-DC at a ratio of 1:4 (DC:T-
cell) in the presence of 100 pg ml−1 staphylococcus enterotoxin
B (SEB) and 10 U ml−1 IL-2 (R&D systems). Cells were cultured
for up to 12 days and then quiescent T-cells were restimulated
with 10 ng ml−1 PMA and 1 μg ml−1 ionomycin for 5 h in the
presence of 10 μg ml−1 Brefeldin A. After 5 h, an aliquot T-cells
were labelled for surface expression of CD3 with a CD3 PerCP-
Cy5.5-conjugated antibody (eBioscience). Cells were then
fixed with 4% PFA and then permeabilized with 0.5% saponin
in order to stain for intracellular cytokines. T-cells were then
labelled with antibodies to IL-4 and IFN-γ conjugated with
PE and FITC (Invitrogen) respectively. Cells were then fixed
and analysed by flow cytometry using a FACScalibur (BD
Biosciences). Alongside this a separate aliquot of cells was also
taken and labelled for caspase activity using a Vybrant FAM
Poly Caspase Assay Kit. Cells that were undergoing apoptosis
were caspase positive and excluded from analysis. At least
50 000 T-cells were collected as defined by CD3 expression
and forward and side scatter profiles. Data were analysed using
FlowJo.
To assess Th17 T-cell differentiation stimulated DC were
co-cultured with allogeneic memory CD4+ T-cells. DC were
stimulated with 10 μg ml−1 Staphlococcus aureus peptidoglycan
as a positive control for Th17 differentiation, Poly I:C (20 μg ml−1)
was used as a negative control. Memory CD4+ T-cells were
isolated using a Memory CD4+ T-cell isolation kit (Miltenyi Biotec)
and then co-cultured with stimulated-DC at a ratio of 1:10 (DC:T-
cell) in the presence of 100 pg ml−1 SEB and 2 U ml−1 IL-2 for up
to 5 days. Cells were restimulated as before with PMA, Ionomycin
and Brefeldin A and then stained for IL-17 production using an
IL-17 PE-conjugated antibody (eBioscience). Cell were analysed
using flow cytometry and at least 50 000 T-cells were collected
and analysed.
Murine immunizations
All animal experiments were approved by the UCL Biological
Services Committee and the Home Office (UK) under Project
License PPL70/6510. All experimental procedures were in line
with current UK Home Office guidelines.
Four groups of 15 female BALB/c mice aged 6–8 weeks
(Charles River UK) were immunized with 5 μg of lgtB, lpxL1,
lgtB/lpxL1 or PBS on days 0, 14 and 28. On day 42 mice were
terminally bled and sera was stored at −80°C for analysis of
specific antibody by ELISA and SBA.
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Antigen-specific antibodies
Specific IgG was determined by whole-cell ELISA. Briefly, 96-well
ELISA plates were coated with 100 μl per well of 0.5% parafor-
maldehyde fixed Nm (OD 0.05 at A600) overnight at RT. Plates
were washed with ELISA buffer (PBS + 0.05% Tween 80) and
then 100 μl of sera serially diluted with PBS + 0.1% Tween 80
was added to each well. After 1 h incubation at 37°C, plates were
washed and then 100 μl of 1/5000 dilution of goat anti-mouse
IgG-HRP was added to each well. Plates were incubated for a
further 1 h at 37°C. Plates were washed and then developed
3,3′,5,5′-Tetramethylbenzidine (TMB). After 10 min the reaction
was stopped with 3 M sulfuric acid and read at A450. The antibody
titre was calculated as the reciprocal dilution that gave an optical
density of 0.6.
Serum bactericidal assay (SBA)
Sera was diluted 1:5 with GBSS + 0.5% BSA and then heat
inactivated at 56°C for 30 min. Twofold serial dilutions were
made, these were then incubated with wild-type or PorA-deficient
Nm H44/76 (104 cfu ml−1) for 15 min at RT. Following incubation
baby rabbit complement was added to a final volume of 20% and
left for 1 h at 37°C. Bacteria were plated on GC agar supple-
mented with Vitox (Oxoid) and grown overnight in a humidified
incubator at 37°C 5% CO2. The serum bactericidal titre was
defined as the reciprocal dilution that resulted in 90% bacterial
killing.
Statistical analysis
Data were analysed using paired T-test, Friedman test (a non-
parametric test that ranks differences in responses of individual
donors to different stimuli (NOMV), taking into account the vari-
ability often observed with human donors), or Fishers Exact Test
(responders versus non-responders) using GraphPad Prism soft-
ware. These are stated in the text when used. Significance was
defined as P < 0.05.
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